Adenosine A1 receptor activation modulates N-methyl-d-aspartate (NMDA) preconditioning phenotype in the brain

Behav Brain Res. 2015 Apr 1:282:103-10. doi: 10.1016/j.bbr.2014.12.056. Epub 2014 Dec 31.

Abstract

N-methyl-d-aspartate (NMDA) preconditioning is induced by subtoxic doses of NMDA and it promotes a transient state of resistance against subsequent lethal insults. Interestingly, this mechanism of neuroprotection depends on adenosine A1 receptors (A1R), since blockade of A1R precludes this phenomenon. In this study we evaluated the consequences of NMDA preconditioning on the hippocampal A1R biology (i.e. expression, binding properties and functionality). Accordingly, we measured A1R expression in NMDA preconditioned mice (75mg/kg, i.p.; 24h) and showed that neither the total amount of receptor, nor the A1R levels in the synaptic fraction was altered. In addition, the A1R binding affinity to the antagonist [(3)H] DPCPX was slightly increased in total membrane extracts of hippocampus from preconditioned mice. Next, we evaluated the impact of NMDA preconditioning on A1R functioning by measuring the A1R-mediated regulation of glutamate uptake into hippocampal slices and on behavioral responses in the open field and hot plate tests. NMDA preconditioning increased glutamate uptake into hippocampal slices without altering the expression of glutamate transporter GLT-1. Interestingly, NMDA preconditioning also induced antinociception in the hot plate test and both effects were reversed by post-activation of A1R with the agonist CCPA (0.2mg/kg, i.p.). NMDA preconditioning or A1R modulation did not alter locomotor activity in the open field. Overall, the results described herein provide new evidence that post-activation of A1R modulates NMDA preconditioning-mediated responses, pointing to the importance of the cross-talk between glutamatergic and adenosinergic systems to neuroprotection.

Keywords: Adenosine A(1) receptors; Glutamate; Hippocampus; NMDA preconditioning; Pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives
  • Adenosine / pharmacology
  • Adenosine A1 Receptor Antagonists / pharmacology
  • Animals
  • Behavior, Animal / drug effects*
  • Excitatory Amino Acid Agonists / pharmacology*
  • Excitatory Amino Acid Transporter 2 / metabolism
  • Glutamic Acid / metabolism
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Locomotion / drug effects
  • Male
  • Mice
  • Mice, Inbred Strains
  • Motor Activity / drug effects
  • N-Methylaspartate / pharmacology*
  • Purinergic P1 Receptor Agonists / pharmacology
  • Receptor, Adenosine A1 / metabolism*
  • Xanthines / pharmacology

Substances

  • Adenosine A1 Receptor Antagonists
  • Excitatory Amino Acid Agonists
  • Excitatory Amino Acid Transporter 2
  • Purinergic P1 Receptor Agonists
  • Receptor, Adenosine A1
  • Xanthines
  • 2-chloro-N(6)cyclopentyladenosine
  • Glutamic Acid
  • N-Methylaspartate
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Adenosine